Found: 42
Select item for more details and to access through your institution.
Artifactual prolongation of the activated partial thromboplastin time by amikacin or gentamicin with ellagic acid, but not silica activated reagent.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Activating transcription factor 4, an ER stress mediator, is required for, but excessive ER stress suppresses osteoblastogenesis by bortezomib.
- Published in:
- International Journal of Hematology, 2013, v. 98, n. 1, p. 66, doi. 10.1007/s12185-013-1367-z
- By:
- Publication type:
- Article
Association of Th1 and Th2 cytokines with transient inflammatory reaction during lenalidomide plus dexamethasone therapy in multiple myeloma.
- Published in:
- International Journal of Hematology, 2013, v. 97, n. 6, p. 743, doi. 10.1007/s12185-013-1321-0
- By:
- Publication type:
- Article
Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Delayed treatment with vitamin C and N-acetyl-L-cysteine protects Schwann cells without compromising the anti-myeloma activity of bortezomib.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Transient inflammatory reaction during lenalidomide plus reduced-dose dexamethasone therapy in two patients with relapsed multiple myeloma.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
Marked improvement of platelet transfusion refractoriness after bortezomib therapy in multiple myeloma.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Raman microspectroscopy for label‐free diagnosis of amyloid light‐chain amyloidosis in various organs.
- Published in:
- Journal of Raman Spectroscopy, 2024, v. 55, n. 7, p. 753, doi. 10.1002/jrs.6665
- By:
- Publication type:
- Article
Dehydroepiandrosterone Sulfate, an Adrenal Androgen, Is Inversely Associated with Prevalence of Dynapenia in Male Individuals with Type 2 Diabetes.
- Published in:
- Metabolites (2218-1989), 2023, v. 13, n. 11, p. 1129, doi. 10.3390/metabo13111129
- By:
- Publication type:
- Article
Clinical Impact of Antipolyethylene Glycol (PEG) Antibody in Hematological Patients Administered PEGylated‐Granulocyte Colony‐Stimulating Factor.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 8, p. 826, doi. 10.1002/cpdd.1225
- By:
- Publication type:
- Article
Correlation between high serum alkaline phosphatase levels and denosumab‐related hypocalcemia in patients with multiple myeloma.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 2, p. 355, doi. 10.1111/bjh.15837
- By:
- Publication type:
- Article
Class 1 HDAC and HDAC6 inhibition inversely regulates CD38 induction in myeloma cells via interferon‐α and ATRA.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 5, p. 969, doi. 10.1111/bjh.15673
- By:
- Publication type:
- Article
Pim‐2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 4, p. 581, doi. 10.1111/bjh.14388
- By:
- Publication type:
- Article
Unique anti‐myeloma activity by thiazolidine‐2,4‐dione compounds with Pim inhibiting activity.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 2, p. 246, doi. 10.1111/bjh.15033
- By:
- Publication type:
- Article
Lipopolysaccharide-Induced CXCL10 mRNA Level and Six Stimulant-mRNA Combinations in Whole Blood: Novel Biomarkers for Bortezomib Responses Obtained from a Prospective Multicenter Trial for Patients with Multiple Myeloma.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0128662
- By:
- Publication type:
- Article
Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0083905
- By:
- Publication type:
- Article
Inhibition of TACE Activity Enhances the Susceptibility of Myeloma Cells to TRAIL.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0031594
- By:
- Publication type:
- Article
Glycolysis Inhibition Inactivates ABC Transporters to Restore Drug Sensitivity in Malignant Cells.
- Published in:
- PLoS ONE, 2011, v. 6, n. 11, p. 1, doi. 10.1371/journal.pone.0027222
- By:
- Publication type:
- Article
TGF-β Inhibition Restores Terminal Osteoblast Differentiation to Suppress Myeloma Growth.
- Published in:
- PLoS ONE, 2010, v. 5, n. 3, p. 1, doi. 10.1371/journal.pone.0009870
- By:
- Publication type:
- Article
The Respiratory Adjusted Shock Index at Admission Is a Valuable Predictor of In-Hospital Outcomes for Elderly Emergency Patients with Medical Diseases at a Japanese Community General Hospital.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 16, p. 4866, doi. 10.3390/jcm13164866
- By:
- Publication type:
- Article
Causes of In-Hospital Death and Pharmaceutical Associations with Age of Death during a 10-Year Period (2011–2020) in Individuals with and without Diabetes at a Japanese Community General Hospital.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 5, p. 1283, doi. 10.3390/jcm13051283
- By:
- Publication type:
- Article
The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 929, doi. 10.3390/cancers12040929
- By:
- Publication type:
- Article
Polyclonal Immunoglobulin Recovery after Autologous Stem Cell Transplantation Is an Independent Prognostic Factor for Survival Outcome in Patients with Multiple Myeloma.
- Published in:
- Cancers, 2020, v. 12, n. 1, p. 12, doi. 10.3390/cancers12010012
- By:
- Publication type:
- Article
Intravenous busulfan-based conditioning with autologous stem cell transplantation for refractory B-cell lymphoma with central nervous system involvement.
- Published in:
- Journal of Medical Investigation, 2021, v. 68, n. 1/2, p. 196, doi. 10.2152/jmi.68.196
- By:
- Publication type:
- Article
Effect of serum concentration and concomitant drugs on vancomycin-induced acute kidney injury in haematologic patients: a single-centre retrospective study.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 12, p. 1695, doi. 10.1007/s00228-019-02756-4
- By:
- Publication type:
- Article
P-023: Assessment of liver stiffness with shear wave elastography for hepatic AL amyloidosis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S52, doi. 10.1016/S2152-2650(21)02157-1
- By:
- Publication type:
- Article
P-005: Novel strategy of elotuzumab and zoledronic acid with Th1-like γδT cells against myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S41, doi. 10.1016/S2152-2650(21)02139-X
- By:
- Publication type:
- Article
Polyclonal immunoglobulin recovery after autologous stem cell transplantation is an independent prognosis factor for survival in patients with multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e215, doi. 10.1016/j.clml.2019.09.358
- By:
- Publication type:
- Article
Synergistic targeting of Sp1 in myeloma cells with hyperthermia plus proteasome inhibitors.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e132, doi. 10.1016/j.clml.2019.09.219
- By:
- Publication type:
- Article
Targeting myeloma metabolisms regulated by HDAC1-IRF4 axis can be a novel therapeutic strategy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e105, doi. 10.1016/j.clml.2019.09.173
- By:
- Publication type:
- Article
Human immunodeficiency virus-positive secondary syphilis mimicking cutaneous T-cell lymphoma.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents.
- Published in:
- Journal of Bone & Mineral Metabolism, 2023, v. 41, n. 3, p. 388, doi. 10.1007/s00774-023-01403-4
- By:
- Publication type:
- Article
Ex vivo expansion and activation of Vγ9Vδ2 T cells by CELMoDs in combination with zoledronic acid.
- Published in:
- International Journal of Hematology, 2024, v. 119, n. 6, p. 626, doi. 10.1007/s12185-024-03763-7
- By:
- Publication type:
- Article
Acute suppression of translation by hyperthermia enhances anti-myeloma activity of carfilzomib.
- Published in:
- International Journal of Hematology, 2024, v. 119, n. 3, p. 291, doi. 10.1007/s12185-023-03706-8
- By:
- Publication type:
- Article
Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors.
- Published in:
- International Journal of Hematology, 2024, v. 119, n. 3, p. 303, doi. 10.1007/s12185-023-03705-9
- By:
- Publication type:
- Article
Involvement of oral bacteria and oral immunity as risk factors for chemotherapy-induced fever with neutropenia in patients with hematological cancer.
- Published in:
- International Journal of Hematology, 2020, v. 112, n. 6, p. 851, doi. 10.1007/s12185-020-02975-x
- By:
- Publication type:
- Article
Cross-Sectional and Longitudinal Associations between Skin Autofluorescence and Tubular Injury Defined by Urinary Excretion of Liver-Type Fatty Acid-Binding Protein in People with Type 2 Diabetes.
- Published in:
- Biomedicines, 2023, v. 11, n. 11, p. 3020, doi. 10.3390/biomedicines11113020
- By:
- Publication type:
- Article
KRN5500, a spicamycin derivative, exerts anti-myeloma effects through impairing both myeloma cells and osteoclasts.
- Published in:
- British Journal of Haematology, 2011, v. 155, n. 3, p. 328, doi. 10.1111/j.1365-2141.2011.08844.x
- By:
- Publication type:
- Article
Cryptosporidiosis in a transplant recipient with severe intractable diarrhea: Detection of <italic>Cryptosporidium</italic> oocysts by intestinal biopsies.
- Published in:
- Transplant Infectious Disease, 2018, v. 20, n. 2, p. 1, doi. 10.1111/tid.12826
- By:
- Publication type:
- Article
Up-regulation of hexokinaseII in myeloma cells: targeting myeloma cells with 3-bromopyruvate.
- Published in:
- Journal of Bioenergetics & Biomembranes, 2012, v. 44, n. 1, p. 31, doi. 10.1007/s10863-012-9412-9
- By:
- Publication type:
- Article
Therapeutic efficacy of the resorcylic acid lactone LL‐Z1640‐2 for adult T‐cell leukaemia/lymphoma.
- Published in:
- EJHaem, 2023, v. 4, n. 3, p. 667, doi. 10.1002/jha2.758
- By:
- Publication type:
- Article
The importance of retaining physical functions to prevent skeletal‐related events in multiple myeloma patients with bone disease.
- Published in:
- EJHaem, 2022, v. 3, n. 2, p. 480, doi. 10.1002/jha2.402
- By:
- Publication type:
- Article